Botanical species · safety record

Actinidia deliciosa

The EFSA Compendium of Botanicals holds 8 constituent measurements and 2 adverse-effect records for Actinidia deliciosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Actinidia deliciosa (A.Chev.) C.F. Liang & A.R. Ferguson

8Constituent measurements

2Safety records

4Cited sources

52Licensed products (Canada)

Also recorded as

Actinidia chinensis var. deliciosa (A.Chev.) A.Chev.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 52 licensed products naming Actinidia deliciosa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Edible fruit part
Fruit
Fruit flesh
Rhizome bark
Seed(s)

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Benzaldehyde	Fruit unspecified	—	—	Gaschromatography (GC)	Resolve DOI
Benzophenone derivatives	Fruit unspecified	—	—	Gaschromatography (GC)	Resolve DOI
Coumarins	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Hydroxymethylfurfural	Fruit unspecified	—	—	Gaschromatography (GC)	Resolve DOI
Myrcene	Fruit unspecified	—	—	Gaschromatography (GC)	Resolve DOI
Oxalic acid	Fruit unspecified	—	—	Gaschromatography (GC)	Resolve DOI
Isoflavones	Fruit unspecified	Solvent extraction	< 0.01 Microgram/gram	LC-MS	No resolvable identifier
Lignans	Fruit unspecified	Solvent extraction	1.11 Microgram/gram	LC-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Leaves	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	Leaves	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Benalla, W., Bellahcen, S., Bnouham, M. Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors. Current diabetes reviews, 2010, vol. 6, no. 4, p. 247-254. DOI
Pereira, Joao., Pereira, Jorge., Camara, Jose S. Effectiveness of different solid-phase microextraction fibres for differentiation of selected Madeira island fruits based on their volatile metabolite profile-Identification of novel compounds . Talanta, 2011, vol. 83, no. 3, p. 899-906. DOI
Kuhnle, Gunter G. C., Dell'Aquila, Caterina., Aspinall, Sue M., Runswick, Shirley A., Joosen, Annemiek M. C. P., Mulligan, Angela A., Bingham, Sheila A. Phytoestrogen content of fruits and vegetables commonly consumed in the UK based on LC-MS and 13C-labelled standards. Food Chemistry, 2009, p. 542-554.
Fu Wen-Wei., Tan Chang-Heng., Lu Lu-Lu., Meng Xiang-Xue., Luo Hong-Feng., Zhu Da-Yuan. Chemical Constituents from the Root of Actinidia deliciosa. Chinese journal of natural medicines, 2010, vol. 8, no. 4, p. 247-249. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature